Search

San Ming R. Hui

Examiner (ID: 18879, Phone: (571)272-0626 , Office: P/1621 )

Most Active Art Unit
1627
Art Unit(s)
1628, 1627, 1617, 1629, 1621
Total Applications
2249
Issued Applications
1013
Pending Applications
287
Abandoned Applications
980

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19065626 [patent_doc_number] => 20240100052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => METHODS FOR REDUCING LIVER FAT and FOR TREATING FATTY LIVER DISORDERS [patent_app_type] => utility [patent_app_number] => 18/518289 [patent_app_country] => US [patent_app_date] => 2023-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20244 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18518289 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/518289
METHODS FOR REDUCING LIVER FAT and FOR TREATING FATTY LIVER DISORDERS Nov 21, 2023 Issued
Array ( [id] => 19447281 [patent_doc_number] => 20240307411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF DISEASE [patent_app_type] => utility [patent_app_number] => 18/515702 [patent_app_country] => US [patent_app_date] => 2023-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19909 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18515702 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/515702
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF DISEASE Nov 20, 2023 Pending
Array ( [id] => 19170856 [patent_doc_number] => 20240156830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => OPHTHALMIC COMPOSITIONS OF RIFAMYCINS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/507906 [patent_app_country] => US [patent_app_date] => 2023-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10104 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18507906 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/507906
OPHTHALMIC COMPOSITIONS OF RIFAMYCINS AND USES THEREOF Nov 12, 2023 Pending
Array ( [id] => 19031515 [patent_doc_number] => 20240081330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => DUAL ACTIVE INSECTICIDAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/505726 [patent_app_country] => US [patent_app_date] => 2023-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6923 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18505726 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/505726
DUAL ACTIVE INSECTICIDAL COMPOSITIONS Nov 8, 2023 Pending
Array ( [id] => 19043509 [patent_doc_number] => 11932593 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-03-19 [patent_title] => 8-(3-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound [patent_app_type] => utility [patent_app_number] => 18/385648 [patent_app_country] => US [patent_app_date] => 2023-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3676 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18385648 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/385648
8-(3-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound Oct 30, 2023 Issued
Array ( [id] => 19462328 [patent_doc_number] => 20240315997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => METHOD OF TREATMENT OF PARKINSON'S DISEASE [patent_app_type] => utility [patent_app_number] => 18/384091 [patent_app_country] => US [patent_app_date] => 2023-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36727 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18384091 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/384091
METHOD OF TREATMENT OF PARKINSON'S DISEASE Oct 25, 2023 Abandoned
Array ( [id] => 19216205 [patent_doc_number] => 20240180909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-06 [patent_title] => Dosing Regimens for Elagolix [patent_app_type] => utility [patent_app_number] => 18/494554 [patent_app_country] => US [patent_app_date] => 2023-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8892 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18494554 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/494554
Dosing Regimens for Elagolix Oct 24, 2023 Abandoned
Array ( [id] => 20479275 [patent_doc_number] => 12527737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-20 [patent_title] => Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors [patent_app_type] => utility [patent_app_number] => 18/491503 [patent_app_country] => US [patent_app_date] => 2023-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 10380 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18491503 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/491503
Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors Oct 19, 2023 Issued
Array ( [id] => 18970331 [patent_doc_number] => 20240050423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => USE OF PRIDOPIDINE FOR THE TREATMENT OF ANXIETY AND DEPRESSION [patent_app_type] => utility [patent_app_number] => 18/489863 [patent_app_country] => US [patent_app_date] => 2023-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10945 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18489863 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/489863
USE OF PRIDOPIDINE FOR THE TREATMENT OF ANXIETY AND DEPRESSION Oct 18, 2023 Abandoned
Array ( [id] => 19155990 [patent_doc_number] => 20240148696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => LYOPHILIZED BENDAMUSTINE-CYCLODEXTRIN COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/380441 [patent_app_country] => US [patent_app_date] => 2023-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4773 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18380441 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/380441
LYOPHILIZED BENDAMUSTINE-CYCLODEXTRIN COMPOSITION Oct 15, 2023 Pending
Array ( [id] => 18953536 [patent_doc_number] => 20240041863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/484249 [patent_app_country] => US [patent_app_date] => 2023-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8055 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18484249 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/484249
COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS Oct 9, 2023 Abandoned
Array ( [id] => 19784175 [patent_doc_number] => 20250057854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF MOTION SICKNESS AND EMESIS [patent_app_type] => utility [patent_app_number] => 18/377510 [patent_app_country] => US [patent_app_date] => 2023-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 135342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18377510 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/377510
COMPOSITIONS AND METHODS FOR THE TREATMENT OF MOTION SICKNESS AND EMESIS Oct 5, 2023 Pending
Array ( [id] => 18953535 [patent_doc_number] => 20240041862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/482456 [patent_app_country] => US [patent_app_date] => 2023-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8031 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18482456 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/482456
COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS Oct 5, 2023 Abandoned
Array ( [id] => 19403513 [patent_doc_number] => 20240287024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF [patent_app_type] => utility [patent_app_number] => 18/481539 [patent_app_country] => US [patent_app_date] => 2023-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22497 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18481539 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/481539
Rho kinase inhibitor ba-1049 (r) and active metabolites thereof Oct 4, 2023 Issued
Array ( [id] => 19186124 [patent_doc_number] => 20240165037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => Colonic Microbiota Responsive Polymer And Its Preparation Method And Use [patent_app_type] => utility [patent_app_number] => 18/474990 [patent_app_country] => US [patent_app_date] => 2023-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7766 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18474990 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/474990
Colonic microbiota responsive polymer and its preparation method and use Sep 25, 2023 Issued
Array ( [id] => 19432498 [patent_doc_number] => 20240300996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => COMPOUNDS FOR TREATING CNS DISORDERS [patent_app_type] => utility [patent_app_number] => 18/473702 [patent_app_country] => US [patent_app_date] => 2023-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69923 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -68 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18473702 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/473702
COMPOUNDS FOR TREATING CNS DISORDERS Sep 24, 2023 Pending
Array ( [id] => 19096294 [patent_doc_number] => 20240115521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL DISEASES [patent_app_type] => utility [patent_app_number] => 18/470317 [patent_app_country] => US [patent_app_date] => 2023-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12329 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18470317 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/470317
COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL DISEASES Sep 18, 2023 Pending
Array ( [id] => 18893700 [patent_doc_number] => 20240009185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/467705 [patent_app_country] => US [patent_app_date] => 2023-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8029 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18467705 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/467705
COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS Sep 13, 2023 Abandoned
Array ( [id] => 19279107 [patent_doc_number] => 20240215578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => POLYSUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES, PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/368514 [patent_app_country] => US [patent_app_date] => 2023-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6545 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18368514 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/368514
POLYSUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES, PREPARATION METHOD AND USE THEREOF Sep 13, 2023 Pending
Array ( [id] => 19316690 [patent_doc_number] => 20240238230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/463873 [patent_app_country] => US [patent_app_date] => 2023-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17784 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18463873 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/463873
METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF Sep 7, 2023 Pending
Menu